Hiroaki Matsubara
About
In The Last Decade
Hiroaki Matsubara
345 papers receiving 14.8k citations
Hit Papers
Peers
Comparison fields: 5 of 164
- Molecular Biology 6.8k
- Cardiology and Cardiovascular Medicine 5.5k
- Surgery 3.2k
- Endocrinology, Diabetes and Metabolism 2.4k
- Genetics 2.2k
Countries citing papers authored by Hiroaki Matsubara
This map shows the geographic impact of Hiroaki Matsubara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Matsubara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Matsubara more than expected).
Fields of papers citing papers by Hiroaki Matsubara
This network shows the impact of papers produced by Hiroaki Matsubara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Matsubara. The network helps show where Hiroaki Matsubara may publish in the future.
Co-authorship network of co-authors of Hiroaki Matsubara
This figure shows the co-authorship network connecting the top 25 collaborators of Hiroaki Matsubara. A scholar is included among the top collaborators of Hiroaki Matsubara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroaki Matsubara. Hiroaki Matsubara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 4 | |
| 3 | 6 | |
| 4 | 14 | |
| 5 | 1 | |
| 6 | Retraction:Effects of Valsartan on Cardiovascular Morbidity and Mortality in High-Risk Hypertensive Patients With New-Onset Diabetes Mellitus:– Sub-Analysis of the KYOTO HEART Study – | 1 |
| 7 | 32 | |
| 8 | 137 | |
| 9 | 5 | |
| 10 | FRS-015 The Feasibility of ^ Tc-Annexin V to Evaluate the Anti-atherosclerotic Therapy by HMG-CoA Reductase Inhibitor Pravastatin in Cholesterol-fed Rabbits(Topics in Nuclear Cardiology(I),Featured Research Session,The 72nd Annual Scientific Meeting of the Japanese Circulation Society) | 0 |
| 11 | 0 | |
| 12 | 30 | |
| 13 | 18 | |
| 14 | Medium-Term Prognosis of Young Japanese Adults Having Acute Myocardial Infarction(CLINICAL INVESTIGATION) | 3 |
| 15 | Importance to shorten door to balloon time in primary angioplasty for acute myocardial infarction | 1 |
| 16 | Evaluation of Potential Side-Effects by Implantation of Bone Marrow-Derived Mononuclear Cells (BM-MNCs) into Porcine Ischemic Myocardium | 1 |
| 17 | 37 | |
| 18 | 65 | |
| 19 | 8 | |
| 20 | 40 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.